{"id":380562,"date":"2020-11-12T20:33:14","date_gmt":"2020-11-13T01:33:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380562"},"modified":"2020-11-12T20:33:14","modified_gmt":"2020-11-13T01:33:14","slug":"aequus-announces-anne-stevens-leadership-change","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/","title":{"rendered":"Aequus Announces Anne Stevens\u2019 Leadership Change"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">VANCOUVER, British Columbia, Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: <a href=\"http:\/\/web.tmxmoney.com\/quote.php?qm_symbol=AQS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">AQS<\/a>, OTCQB: <a href=\"http:\/\/www.otcmarkets.com\/stock\/AQSZF\/quote\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">AQSZF<\/a>), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announces Ms Anne Stevens is stepping down from her role as Chief Operating Officer. Ms Stevens will remain a Director and will continue to serve on the Aequus Board of Directors.<\/p>\n<p>\u201cAnne and I co-founded Aequus together and I want to thank her for her many contributions over the years,\u201d said Doug Janzen, Chairman and CEO of Aequus. \u201cAnne is an incredibly talented and effective executive who is leaving the company in excellent shape and well positioned for success in the years to come. We are excited about her future plans and look forward to her continued work with the Aequus Board.\u201d<\/p>\n<p>\u201cI want to thank my fellow Directors and the entire team at Aequus,\u201d said Ms Stevens. \u201cIt is extraordinary to see how Aequus has grown to be the mature commercial entity it is today, with a sharp focus and great momentum towards being a meaningful contributor to the Eye Care landscape in Canada. I believe that the commercial team is well prepared for my departure under the leadership of Grant Larsen and I look forward to watching a strong launch of the Evolve line of eye care products in Canada.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About <\/strong><br \/>\n        <strong>Aequus<\/strong><br \/>\n        <strong> Pharmaceuticals <\/strong>\n      <\/p>\n<p>Aequus Pharmaceuticals Inc. (TSX-V: <a href=\"http:\/\/web.tmxmoney.com\/quote.php?qm_symbol=AQS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>AQS<\/u><\/a><a href=\"http:\/\/web.tmxmoney.com\/quote.php?qm_symbol=AQS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">,<\/a> OTCQB: <a href=\"http:\/\/www.otcmarkets.com\/stock\/AQSZF\/quote\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>AQSZF<\/u><\/a><a href=\"http:\/\/www.otcmarkets.com\/stock\/AQSZF\/quote\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">)<\/a> is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several commercial products in ophthalmology and transplant. Aequus plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license; remaining focused on highly specialized therapeutic areas. For further information, please visit <a href=\"http:\/\/www.aequuspharma.ca\/en\/index.htm\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.aequuspharma.ca<\/u><\/a><a href=\"http:\/\/www.aequuspharma.ca\/en\/index.htm\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">.<\/a><\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements:<\/strong>\n      <\/p>\n<p>\n        <em>This release may contain forward-looking statements or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including, without limitation, statements containing the words \u201cbelieve\u201d, \u201cmay\u201d, \u201cplan\u201d, \u201cwill\u201d, \u201cestimate\u201d, \u201ccontinue\u201d, \u201canticipate\u201d, \u201cintend\u201d, \u201cexpect\u201d, \u201cpotential\u201d and similar expressions. Forward- looking statements are necessarily based on estimates and assumptions made by us in light of our <\/em><br \/>\n        <em>experience and perception of historical trends, current conditions and expected future developments, as well as the factors we believe are appropriate. Forward-looking statements include but are not limited to statements relating to<\/em><br \/>\n        <em>: <\/em><br \/>\n        <em>the implementation of our business model and strategic plans; expected timing for product launch; the regulatory approval of the Evolve line of products expected in 2020<\/em><br \/>\n        <em>. Such statements reflect our current views with respect to <\/em><br \/>\n        <em>future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by <\/em><br \/>\n        <em>Aequus<\/em><br \/>\n        <em>, are inherently subject to significant business, economic, competitive, political and <\/em><br \/>\n        <em>social uncertainties and contingencies. Many factors could cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward looking statements included in this release, the Company has made various material assumptions, including, but not limited to: obtaining positive results of clinical trials; obtaining regulatory approvals; general business and economic conditions; the Company\u2019s ability to successfully out license or sell its current products and in-license and develop new products; the assumption that the Company\u2019s current good relationships with its manufacturer and other third parties will be maintained; the availability of financing on reasonable terms; the Company\u2019s ability to attract and retain skilled staff; market competition;<\/em><br \/>\n        <em>the products and technology offered by the Company\u2019s competitors; and the Company\u2019s ability to protect patents and proprietary rights<\/em><br \/>\n        <em>. In evaluating forward looking statements, current and prospective shareholders should specifically consider various factors set out herein and under the heading \u201cRisk Factors\u201d in the Company\u2019s Annual Information Form dated April 28, 2020, a copy of which is available on <\/em><br \/>\n        <em>Aequus<\/em><br \/>\n        <em>\u2019 profile on the SEDAR website at www.sedar.com, and as otherwise disclosed from time to time on <\/em><br \/>\n        <em>Aequus<\/em><br \/>\n        <em>\u2019 SEDAR profile. Should one or more of these risks or uncertainties, or a risk that is not currently known to us materialize, or should assumptions underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this release and we do not intend, and do not assume any obligation, to update these forward-looking statements, except as required by applicable securities laws. Investors are cautioned that forward-looking statements are not guarantees of future performance and are inherently uncertain. Accordingly, investors are cautioned not to put undue reliance on forward looking statements. <\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong>Contact Information:<\/strong>\n      <\/p>\n<p align=\"justify\">Aequus Investor Relations<br \/>Email: investors@aequuspharma.ca<br \/>Phone: 604-336-7906<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announces Ms Anne Stevens is stepping down from her role as Chief Operating Officer. Ms Stevens will remain a Director and will continue to serve on the Aequus Board of Directors. \u201cAnne and I co-founded Aequus together and I want to thank her for her many contributions over the years,\u201d said Doug Janzen, Chairman and CEO of Aequus. \u201cAnne is an incredibly talented and effective executive who is leaving the company in excellent shape and well positioned for success in the years to come. We are excited about her future &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aequus Announces Anne Stevens\u2019 Leadership Change&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380562","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aequus Announces Anne Stevens\u2019 Leadership Change - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aequus Announces Anne Stevens\u2019 Leadership Change - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announces Ms Anne Stevens is stepping down from her role as Chief Operating Officer. Ms Stevens will remain a Director and will continue to serve on the Aequus Board of Directors. \u201cAnne and I co-founded Aequus together and I want to thank her for her many contributions over the years,\u201d said Doug Janzen, Chairman and CEO of Aequus. \u201cAnne is an incredibly talented and effective executive who is leaving the company in excellent shape and well positioned for success in the years to come. We are excited about her future &hellip; Continue reading &quot;Aequus Announces Anne Stevens\u2019 Leadership Change&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T01:33:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aequus Announces Anne Stevens\u2019 Leadership Change\",\"datePublished\":\"2020-11-13T01:33:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/\"},\"wordCount\":796,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/\",\"name\":\"Aequus Announces Anne Stevens\u2019 Leadership Change - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=\",\"datePublished\":\"2020-11-13T01:33:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aequus-announces-anne-stevens-leadership-change\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aequus Announces Anne Stevens\u2019 Leadership Change\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aequus Announces Anne Stevens\u2019 Leadership Change - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/","og_locale":"en_US","og_type":"article","og_title":"Aequus Announces Anne Stevens\u2019 Leadership Change - Market Newsdesk","og_description":"VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announces Ms Anne Stevens is stepping down from her role as Chief Operating Officer. Ms Stevens will remain a Director and will continue to serve on the Aequus Board of Directors. \u201cAnne and I co-founded Aequus together and I want to thank her for her many contributions over the years,\u201d said Doug Janzen, Chairman and CEO of Aequus. \u201cAnne is an incredibly talented and effective executive who is leaving the company in excellent shape and well positioned for success in the years to come. We are excited about her future &hellip; Continue reading \"Aequus Announces Anne Stevens\u2019 Leadership Change\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T01:33:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aequus Announces Anne Stevens\u2019 Leadership Change","datePublished":"2020-11-13T01:33:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/"},"wordCount":796,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/","name":"Aequus Announces Anne Stevens\u2019 Leadership Change - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=","datePublished":"2020-11-13T01:33:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTQ5NCMzODI1NjY1IzIwOTAyMTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aequus-announces-anne-stevens-leadership-change\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aequus Announces Anne Stevens\u2019 Leadership Change"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380562"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380562\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}